In metastatic melanomas, a significant increase in SYNPO2 promoter methylation level was observed compared to non-metastatic melanoma, and SYNPO2 promoter hypermethylation was highly correlated with poor prognosis [13]. Here, SYNPO2 is linked to metastatic melanoma.